IGI Logo
Toggle Navigation
News
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Compare Scheme
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
More
Budget 2024
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Astrology
Beyond Market Car
Beyond Market Entertainment
Beyond Market Fashion
Beyond Market Gadgets
Beyond Market Health
Beyond Market India
Beyond Market Life Style
Beyond Market Sports
Broking Firm Views
Broking Firm Views - Long Term Report
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Budget 2024 Sector Reports
Budget Bites
Budget Economic Servey
Budget Expert Views
Budget Industry
Budget News
Budget Wishlist
Commodities
Commodities Reports
Commodity Top News
Company News
Company Result
Currency News
Currency Report
Currency Top News
Diwali Expert Views
Diwali Market Outlook
Diwali Report
Diwali Technical Report
Economy News
Expert View Institution
Expert Views
Industry News
IPO Analysis
IPO More News
IPO Reports
IPO Top News
Market Outlook
Mutual Fund Analysis
Mutual Fund Expert Views
Mutual Fund More News
Mutual Fund Top News
Podcast - Market Ki Awaaz
Special Event Expert Views
Special Event Reports
Startup
Startup Expections
Startup Speak
Stock Market
Stock On The Move
Top News
Top Stories
Videos
Videos Business
Videos Entertainment
Videos Global News
Videos Lifestyle And Fashion
Videos News And Politics
Videos Sports
Wealth
Women
World Market More News
World Top News
Search
Revenue uptick, margin stability key to positive stance Result Synopsis Vijaya reported a better revenue performance with like for like patient volume growth of 13% YoY adjusted for 50k covid patients in the base quarter. Realization per footfall also surprised on the higher side; increase in volumes led to operating leverage which partly offset the rise in other expenses on account of opening of ~5 hubs and 15-20 spokes in the last 12 months. With newly opened centres like Tirupati, Ra...
Add Vijaya Diagnostic Centre Ltd Target Rs.530 - Yes Securities
New centre costs weigh on earnings Vijaya’s 3Q was tad below JMFe primarily due to seasonality and new hub costs weighing on PAT. However, Dec’22 has seen good volumes (3Y CAGR at ~12%) which are expected to continue in 4Q. We believe EBITDA margins will revert to 40%+ despite these new centre costs driven by higher operating leverage. Non-Covid grew +10%YoY/-4%QoQ with Covid contribution <1% of revenues (vs.8%YoY). B2C share stood at 95% (marginally improved vs. 94% in FY22...
Buy Vijaya Diagnostic Centre For Target Rs. 460 - JM Financial Institutional Securities
Vijaya Diagnostic Centre Ltd. on Thursday, 26 May 2022, has announced Final dividend of 100 percent on Equity Share, to its shareholders holding shares on the register on Wednesday, 21 September 2022 (Record Date). The ex-dividend date will be 20 September 2022.
Vijaya Diagnostic has declared 100% Final dividend for the financial year March 2022
Growth thesis intact Result Synopsis Vijaya reported a marginal miss on margin as Covid revenues jumped YoY – about 35- 40 days in the quarter were impacted particularly on radiology along with change in mix in pathology. Expect pickup from March to drive a better QoQ performance exCovid with support from launch of additional centres. Vijaya was impacted by Covid tests for nearly half of 4Q leading to 2% YoY decline in non Covid revenues. This makes comparison difficult on the ...
Buy Vijaya Diagnostic Centre Ltd Target Rs.5250 - Yes Securities
B2C-focused dominant Southern player Vijaya Diagnostic (Vijaya) is one of the largest integrated diagnostic chains in southern India and is primarily based in Andhra Pradesh and Telangana. Other factors that differentiate Vijaya from other diagnostic chains are: 1) ~92% of business is its B2C (provides stickiness) and 2) it offers a comprehensive basket of diagnostic services in both pathology and radiology. Owing to its B2C focus and higher radiology contribution, Vijaya commands the high...
Buy Vijaya Diagnostic Centre Ltd For Target Rs.700 - ICICI Securities
Below is quote on Vijaya Diagnostic IPO listing by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Vijay Diagnostic Centre Limited ipo debut at premium of 8% to its upper band of the IPO price. Company is trading at price to earning of 67 times and EV/EBITDA OF 32 times based on FY2021 numbers which is on higher side as compared to its peers. Looking at higher valuations and limited growth poten...
Quote on Vijaya Diagnostic IPO listing by Mr. Yash Gupta, Angel Broking Ltd
Below is quote on Vijay Diagnostic IPO expected listing by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Vijay Diagnostic Centre Limited to list on stock exchanges on 14th September 2021, the overall retail portion got subscribed 1.09 times so it was expected that almost all the investors got the allotment. Vijaya Diagnostic IPO is priced at Price to Earnings of 64.3 times and EV/EBITDA of 30 times at the upper price band ...
Quote on Vijay Diagnostic IPO expected listing by Mr. Yash Gupta, Angel Broking Ltd
Below is quote on What should investors expect from the listing of Vijaya Diagnostic Centre Limited IPO? by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Vijaya Diagnostic Centre Limited expect to get a listing on 14th September 2021 and allotment will be received by the investors in a couple of days. As overall IPO got subscribed 4.54 times and the retail portion got subscribed by 1.09 times, so i...
Quote on What should investors expect from the listing of Vijaya Diagnostic Centre Limited IPO? by Mr. Yash Gupta, Angel Broking Ltd
Below is quote on Vijaya Diagnostic Centre Limited IPO struggle to get fully subscribed on Day 3 by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Today is the 3rd and last day for Vijaya Diagnostic Centre Limited IPO and as of now IPO only subscribed by 0.52 times of the overall IPO size. Vijaya diagnostics IPO struggle to get a response from Retail investors as well as Qualified Institutional investors, as of now the reta...
Quote on Vijaya Diagnostic Centre Limited IPO struggle to get fully subscribed on Day 3 by Mr. Yash Gupta, Angel Broking Ltd
Below is quote on Should investors invest in Vijaya Diagnostic IPO? by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Today is the last day for Vijaya Diagnostic IPO, company has fix the price band of ₹522-₹531 with the issue size of ₹1,894 crores at upper price band. Vijaya Diagnostic Centre is the largest integrated diagnostic chain in southern India. Vijaya Diagnostic provides integrated services of pathology and radiology. V...
Quote on Should investors invest in Vijaya Diagnostic IPO? by Mr. Yash Gupta, Angel Broking Ltd
Below is quote on Vijaya Diagnostics Weak response on Day 1 and GMP by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Vijaya Diagnostic received a weak response from investors on 1st day of the IPO and GMP comes down to ₹15. Vijaya Diagnostic Centre Limited IPO opens on 1st September 2021 with an IPO price band of ₹522-₹531 and IPO issue size of ₹1894 crores at the upper price band. On the first day of the subscr...
Quote on Vijaya Diagnostics Weak response on Day 1 and GMP by Mr. Yash Gupta, Angel Broking Ltd
Vijaya Diagnostic Centre Ltd (VDCL), established in 2002, is one of the fastest-growing diagnostic chains of Southern India (Andhra Pradesh and Telangana). VDCL has a strong brand recall in the South Indian diagnostic market, offering one stop, high quality affordable diagnostic services to consumers. VDCL offers pathology (740 routine tests, 870 specialized tests and 220 basic tests) and 320 advanced radiology tests across its 81 centers. The company sources over 93% of its revenue from i...
IPO Note - Vijaya Diagnostic Centre Ltd By Ventura Securities
Largest integrated diagnostic chain in South India Vijaya Diagnostic Centre (VDCL) is one of the largest integrated diagnostic chain in South India, having a dominant market share and brand recall in the Telangana and Andhra Pradesh. After starting in 1981, the company has 81 diagnostic centres in 13 cities/towns. It has 7% share in Telangana and Andhra non-hospital diagnostic market. Promoted by S. Surendranath Reddy, promoters own 60% stake while rest is owned by PE firm Kedaara Capital....
IPO Note - Vijaya Diagnostic Centre Ltd By Yes Securities
Below is quote on Vijaya Diagnostic Centre IPO by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Background - Vijaya Diagnostic Centre was incorporated in 2002, and is the largest integrated diagnostic chain in southern India. Vijaya Diagnostic provides integrated services of pathology and radiology and offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. Vijaya dia...
Quote on Vijaya Diagnostic Centre IPO by Mr. Yash Gupta, Angel Broking Ltd
Company Overview Vijaya Diagnostics Ltd (VDL) is the largest integrated diagnostic chain in southern India, by operating revenue. It offers a one-stop solution for pathology and radiology testing services to its customers through its extensive operational network, which consists of 81 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana and Andhra Pradesh and in the National Capital Region and Kolkata as on June 30, 2021. Objec...
IPO Note - Vijaya Diagnostics Ltd By Nirmal Bang
Below is quote and Outlook on Vijaya Diagnostics IPO by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd Based on FY2021 numbers, IPO is priced at a Price to Earning of 64.3 times and EV/EBITDA of 30 times at the upper price band of the IPO, which is in line with the listed peer group. Company already has a higher market share in key geographics like Hyderabad and we do not expect the covid related benefit to continue in coming years. ...
Outlook on Vijaya Diagnostics IPO by Mr. Yash Gupta, Angel Broking Ltd
About the Company Established in 1981, Vijaya Diagnostic Centre Ltd. (Vijaya) is the largest integrated diagnostic chain in southern India, by operating revenue, and also one of the fastest-growing diagnostic chains by revenue for FY20. It offers a one-stop solution for pathology and radiology testing services to customers through its extensive operational network, which consists of 81 diagnostic centres and 11 reference laboratories across 13 cities and towns in the states of Telangana, A...
IPO Note - Vijaya Diagnostic Centre Ltd by Religare Broking
Below is quote on Grey Market Premium of Vijaya Diagnostics IPO by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd What's Grey Market premium suggesting for Vijaya Diagnostics IPO? Vijaya Diagnostics IPO to open on 1st September 2021 with issue size of Rs.1894 crores, the price band of the ...
Quote on Grey Market Premium of Vijaya Diagnostics IPO by Mr. Yash Gupta, Angel Broking Ltd
Salient features of the IPO: * Kedaara Capital-backed Vijaya Diagnostic Centre Ltd. (VDCL), is coming up with an IPO to raise Rs. 1,895cr, which opens on 1st Sept. and closes on 3rd Sept. 2021. The price band is Rs. 522 - 531 per share. * The issue is fully an OFS, so the company will not receive any proceeds from the IPO. Key competitive strengths: * Largest and fastest growing diagnostic chain with dominant position in South India, well positioned to leverage...
IPO Note - Vijaya Diagnostic Centre Ltd By Choice Broking
Load More
